-
Published28/05/2025
-
Today23/06/2025
-
Deadline30/06/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Medicinal products - laxants, antidiarrhoea, intestinal anti-inflammatory and anti-infectious drugs Text automatically translated in your browsing language Automatically translated
The subject of the public contract is the continuous supply of medicinal products containing laxances, antidiarrhoea, intestinal anti-inflammatory and anti-infectious drugs for 4 years according to the current needs of the contracting authority. Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilFNHK
https://www.egordion.cz/nabidkaGORDION/profilFNHK
33610000 - Medicinal products for the alimentary tract and metabolism
33630000 - Medicinal products for dermatology and the musculo-skeletal system CVP code deduced from the text of the procedure AI-generated
33614000 - Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents CVP code deduced from the text of the procedure AI-generated
33632000 - Medicinal products for the musculo-skeletal system CVP code deduced from the text of the procedure AI-generated
33651000 - General anti-infectives for systemic use and vaccines CVP code deduced from the text of the procedure AI-generated
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.